An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action

Epilepsia

Volumn 41, Issue SUPPL. 1, 2000, Pages 3-9

  Shank, Richard P ^a   Gardocki, Joseph F ^a   Streeter, Anthony J ^a   Maryanoff, Bruce E ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

AMPA kainate receptors; Anticonvulsant; Epilepsy; GABAA receptors; Na+ channels; Topiramate

Indexed keywords

EID: 0003150278     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb02163.x     Document Type: Article

References (10)

1. Gardocki JF, Labinsky LS, Brown GL, Maryanoff BE. Anticonvulsant activity of McN-4853 (M) (2,3:4,5-bis-O-[1-methylethylidene]-β-D-fructopyranose sulfamate in mice and rats. Epilepsia 1986;27:648-9.
2. Maryanoff BE, Nortey SO, Gardocki JF, Shank RP, Dodgson SP. Anticonvulsant O-alkyl sulfamates: 2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate and related compounds. J Med Chem 1987;30:880-7.
3. Shank RP, Gardocki JF, Vaught JL, et al. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia 1994; 35:450-60.
4. Dodgson SJ, Shank RP, Maryanoff, BE. Topiramate as an inhibitor of carbonic anhydrase isozymes. Epilepsia 2000;41(suppl 1):S35-9.
5. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 2000;41(suppl 1):S17-20.
6. Nakamura J, Tamura S, Kanda T, Ishii A, Ishihara K, Serikawa T, Yamada J, Sasa M. Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice. Eur J Pharmacol 1994; 254:83-9.
7. Edmonds HL Jr., Jiang YD, Zhang PY, Shank RP. Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy. Life Sci 1996;59:PL127-31.
8. Wauquier A, Zhou S. Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res 1996;24:73-7.
9. Streeter AJ, Stahle PL, Hills JF, et al. Pharmacokinetics of topiramate in the rat. Pharm Res 1994;11(suppl):S372.
10. Easterling DE, Zakszewski T, Moyer MD, et al. Plasma pharmacokinetics of topiramate, a new anticonvulsant, in humans. Epilepsia 1988;29(suppl):662.